Shamim Ruff - 10 Jun 2021 Form 4 Insider Report for REATA PHARMACEUTICALS INC

Role
Director
Signature
/s/ Tracy Herson, attorney-in-fact
Issuer symbol
N/A
Transactions as of
10 Jun 2021
Net transactions value
+$64,927
Form type
4
Filing time
14 Jun 2021, 11:33:43 UTC
Next filing
05 Jan 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RETA Stock Option (right to buy) Award $0 +5,000 $0.000000 5,000 10 Jun 2021 Class A common stock 5,000 $146.01 Direct F1
transaction RETA Stock Option (right to buy) Award $64,927 +780 $83.24 780 10 Jun 2021 Class A common stock 780 $146.01 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest in 4 equal installments on September 10, 2021, December 10, 2021, March 10, 2022, and June 10, 2022, subject to continued service through each vesting date.
F2 This option was issued to the reporting person pursuant to the Reata Non-Employee Director Compensation Policy in lieu of director fees of $65,000.